Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

NCT01189279 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01189279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01189279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
Lead sponsor
Allergan
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
February 28, 2011
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, alopecia, androgenetic, baldness